Working hypothesis: benign febrile seizures seen in 7% of infants before 6 months play a role in the terminal pathway in a subset of sudden infant death syndrome victims. Supporting evidence: (1) lack of 5-hydroxitryptamine, one consistent finding in sudden infant death syndrome that Kinney et al coined a developmental serotonopathy, is consistent with risk for seizures. (2) Non–rapid eye movement sleep increasing during the age of highest risk for sudden infant death syndrome facilitates some seizures (seizure gate). (3) Sudden unexpected death in epilepsy is associated with severe hypoxemia and hypercapnia during postictal generalized electroencephalographic (EEG) suppression. In toddlers, sudden unexplained deaths are associated with hippocampal abnormalities and some seizures. (4) The sudden nature of both deaths warrants an exploration of similarities in the terminal pathway. Moreover, sudden infant death syndrome, febrile seizures, sudden unexplained death in childhood, and sudden unexpected death in epilepsy share some of the following risk factors: prone sleeping, infections, hyperthermia, preterm birth, male gender, maternal smoking, and mutations in genes that regulate sodium channels. State-of-the-art molecular studies can be exploited to test this hypothesis.
RandellB. Witnessed sudden infant death syndrome: a case report. J SIDS Infant Mortal. 1996;1:53–55.
2.
KinneyHCBroadbeltKGHaynesRL. The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis. J Chem Neuroanatomy. 2011;41:182–199.
3.
KinneyHCChadwickAECrandallLA. Sudden death, febrile seizures, and hippocampal and temporal lobe maldevelopment in toddlers: a new entity. Pediatr Dev Pathol. 2009;12:455–463.
4.
RodriguezMLMcMillanKCrandallLA. Hippocampal asymmetry and sudden unexpected death in infancy: a case report. Forensic Sci Med Pathol. 2012;8:441–446.
5.
KinneyHAMcDonaldAGMinterME. Witnessed sleep related seizure and sudden unexpected death in infancy: a case report. Forensic Sci Med Pathol. 2013;9:418–421.
6.
FriedmanMGhazalaQSharieffMD. Seizures in children. Pediatr Clin N Am. 2006;53:257–277.
7.
VestergaardMBassoOHenriksenTB. Febrile convulsions and sudden infant death syndrome. J Arch Dis Child. 2002;86:125–126.
8.
Commission on Epidemiology and Prognosis, International League against Epilepsy. Guidelines for epidemiology studies on epilepsy. Epilepsia. 1993;34:592–596.
9.
Practice parameter: long-term treatment of the child with simple febrile seizures. American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics. 1999;103:1307–1309.
10.
TsuboiT. Okada Seasonal variation of febrile convulsion in Japan. Acta Neurol Scand. 1984;69:285–292.
11.
VestergaardMChristensenJ. Register-based studies on febrile seizures in Denmark. Brain Dev. 2009;31:372–377.
12.
SunYChristensenJHviidA. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and haemophilus influenzae type B. JAMA2012;307:823–831.
13.
PrechtlH. Continuity and change in early neural development. In: PrechtlHF, ed., Continuity of Neural Functions from Prenatal to Postnatal Life. London: Spastics International Medical Publications; 1984:1–15.
14.
KrousHFChadwickAECrandallL. Sudden infant death in childhood: a report of 50 cases. Pediatr Dev Pathol. 2005;8:307–319.
15.
KadhimHSebireGKhalifaM. Incongruent cerebral growth in sudden infant death syndrome. J Child Neurol. 2005;20:244–246.
16.
HsiehDWalkerJMPearlPL. Infantile seizures: infants are not just little children. Curr Neurol Neurosci Rep. 2008;8:139–144.
17.
BrianGRNevilleBGGindnerD. Febrile seizures-semiology in humans and animal models: evidence of focality and heterogeneity. Brain Dev. 2010;32:33–36.
18.
McGovernMCSmithMBH. Causes of apparent life threatening events in infants: a systematic review. Arch Dis Child. 2004;89:1043–1048.
19.
GrayCDaviesFMolyneuxE. Apparent life-threatening events presenting to a pediatric emergency department. Pediatr Emerg Care. 1999;15:195–199.
20.
RichersonGBBuchanonGF. The serotonin axis: shared mechanisms in seizures depression and SUDEP. Epilepsia. 2011;52(suppl 1):28–38.
21.
MilroyCM. Sudden unexpected death in epilepsy in childhood. Forensic Sci Med Pathol. 2011;7:336–340.
Le GalFKorffCMMonso-HinradC. A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation. Epilepsia. 2010;51:1915–1918.
24.
GetahunDAmreDRhoadsGG. Maternal and obstetric risk factors for sudden infant death syndrome in the United States. Obstet Gynecol. 2004;103:646–652.
25.
Task Force on sudden infant death syndrome. MoonRY. SIDS and other sleep-related infant deaths: expansion of recommendations for a safe infant sleeping environment. [Review]Pediatrics. 2011;128:1030–1039.
26.
WallaceSJ. Aetiological aspects of febrile convulsions, pregnancy and perinatal factors. Arch Dis Child. 1972;47:171–178.
27.
SidenvallRHeijbelJBlomquistHK. An incident case-control study of first unprovoked afebrile seizures in children: a population-based study of pre- and perinatal risk factors. Epilepsia. 2001;42:1261–1265.
28.
ChungBWatLCWongV. Febrile seizures in Southern Chinese children: incidence and recurrence. Pediatr Neurol. 2006;34:121–126.
29.
BergATShinnarSShapiroED. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia. 1995;36:334–341.
30.
RakhadeSNJensenFE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. 2009;5:380–391.
31.
GunterothWGSpiersPS. Thermal stress in sudden infant death: is there an ambiguity with the rebreathing hypothesis?Pediatrics. 2001;107:693–698.
32.
WaruiruCAppletonR. Febrile seizures: an update. Arch Dis Child. 2004;89:751–756.
33.
KinneyHCRicharsonGBDymeckieSM. The brainstem and serotonin in the sudden infant death syndrome. Annu Rev Pathol. 2009;4:517–550.
34.
DuncanJRPatersonDSHoffmanJM. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA. 2010;303:430–437.
35.
BagdyGKecskemetiVRibaP. Serotonin and epilepsy. J Neurochem. 2007;100:857–873.
36.
MachaalaniRSayMWatersKA. Serotonergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with risk factors. Acta Neuropathol. 2009;117:257–265.
37.
MorimotoTKidaKNagaoH. The pathogenic role of the NMDA receptor in hyperthermia-induced seizures in developing rats. Brain Res Dev Brain Res. 1995;84:204–207.
38.
GilbertRRuddPBerryPJ. Combined effect of infection and heavy wrapping on the risk of sudden unexpected infant death. Arch Dis Child. 1992;67:171–177.
39.
SzymusiakRGviliaIMcGintyD. Hypothalamic control of sleep. Sleep Med. 2007;8:291–301.
40.
GallandBCTaylorBJBoltonDPG. Prone versus supine sleep position: a review of the physiological studies in SIDS research. J Paediatr Child Health. 2002;38:332–333.
41.
ShouseMNSiegelJMWuMF. Mechanism of seizure suppression during rapid-eye-movement (REM) sleep in cats. Brain Res. 1989;505:271–282.
42.
PopoviciuLBagathaiITudosie-GoriaM. Polysomnographic and computerized electroencephalic studies in myoclonic petit mal epilepsies. Romanian J Neurol Psychiatry. 1993;31:39–54.
43.
NaeyeRL. Hypoxemia and the sudden infant death syndrome. Science. 1974;186:837–838.
44.
Gilbert-BarnessEValdes-DapenaMSteinschneiderA. Reproducibility of Naeye's seven tissue markers of hypoxia. Pediatr Pathol. 1992;12:481–482.
45.
Himms-HagenJ. Cold-versus diet-induced thermogenesis in brown adipose tissue: different strategies in different species. In: HellerHMusacchiaXJWangLCH, eds. Living in the Cold Physiological and Biochemical Adaptations.New York:Elsevier Science1986, pp 93–100.
46.
HollowayRDavidsonRGFreemanS. Postnatal development of interscapular brown adipose tissue in the guinea pig: effect of environmental temperature. Int J Obes. 1984;8:295–303.
47.
MourouxJBertinRPortetR. Thermogenic capacity of the brown adipose tissue of developing rats; effects of rearing temperature. J Dev Physiol. 1990;14:337–342.
48.
KahnAWachholderAWinklerM. Prospective study on the prevalence of sudden infant death and possible risk factors in Brussels: preliminary results (1987-1988). Eur J Pediatr. 1990;149:284–286.
49.
KahnABlumD. Phenothiazines and sudden infant death syndrome. Pediatrics. 1982;70:75–78.
50.
HoppenbrouwersTHodgmanJEArakawaK. Sleep and waking states in infancy: normative studies. Sleep. 1988;11:387–401.
51.
HoppenbrouwersTHodgmanJERybineD. Sleep architecture in term and preterm infants beyond the neonatal period: the influence of gestational age, steroids, and ventilatory support. Sleep. 2005;11:1272–1280.
52.
SlaterPMcConnellSED’SouzaSW. Postnatal changes in N-methyl-D-aspartate receptor binding by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex. Br J Pharmacol. 1993;108:1143–1149.
53.
MachaalaniRWatersKA. NMDA receptor 1 expression in the brainstem of human infants and its relevance to the sudden infant death syndrome (SIDS). J Neuropathol Exp Neurol. 2003;62:1076–1085.
54.
BroadbeltKGPatersonDSBelliveauRA. Decreased GABA A receptor binding in the medullary serotonergic system in the sudden infant death syndrome. J Neuropathol Exp Neurol. 2011;70:799–810.
55.
LoscherWSiemesH. Increased concentration of prostaglandin E-2 in cerebrospinal fluid of children with febrile convulsions. Epilepsia. 1988;29:307–310.
56.
GattiSVezzaniABartfaiT. Mechanism of fever and febrile seizures: putative role of interleukin-1 system. In: BaramTZShinnarS, eds. Febrile Seizures. San Diego, CA: Academic Press; 2002:169–188.
57.
DubeCVezzaniABehrensM. Interleukin-1 beta contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152–155.
58.
KadhimHKahnASébireG. Distinct cytokine profile in SIDS brain. Neurol. 2003;61:1256–1259.
59.
ImeriLOppMR. How (and why) the immune system makes us sleep. Nat Rev Neurosci. 2009;10:199–210.
60.
BakerFCShahSStewartD. Interleukin 1β enhances non-rapid eye movement sleep and increases c-Fos protein expression in the median preoptic nucleus of the hypothalamus. Am J Physiol. 2004;288:R998–R1005.
61.
RiaziKGalicGYousefiR. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010;89:34–42.
62.
VezzaniAMarosoMBalossoS. IL-1 receptor/toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun. 2011;25:1281–1289.
63.
MathewsTJMacDormanMF. Infant mortality statistics from the 2004 period linked birth/infant death data set. Natl Vital Stat Rep. 2007;55:1–32.
64.
SanchezRMJensenFE. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia. 2001;42:577–585.
65.
HewertsonJPoetsCFSamuelsMP. Epileptic seizure-induced hypoxemia in infants with apparent life-threatening events. Pediatrics. 1994;94:148–156.
66.
BlumASIvesJRGoldbergerAL. Oxygen desaturations triggered by partial seizures implications for cardiopulmonary instability in epilepsy. Epilepsia. 2000;41:536–541.
67.
TomsonTNashefLRyvlinP. Sudden unexpected death in epilepsy current knowledge a future directions. Lancet Neurol. 2008;7:1021–1031.
68.
PoetsCFMenyRGChobabianMR. Gasping and other cardiorespiratory patterns during sudden infant deaths. Pediatr Res. 1999;45:350–354.
69.
SchueleSU. Effects of seizures on cardiac function. J Clin Neurophysiol. 2009;26:302–308.
70.
KlassenTBombenVCPatelAP. High-resolution molecular genomic autopsy reveals complex sudden unexpected death in epilepsy risk profile. Epilepsia. 2014;55:6–12.
71.
Weese-MayerDEAckermanMJMarazitaML. Sudden infant death syndrome review of implicated genetic factors. Am J Med Genet. 2007;Part A 143A:771–788.
72.
WedekindHSmitsJPSchulze-BahrE. De novo mutation in the SCN5A gene associated with early onset sudden infant death syndrome. Circulation. 2001;104:1158–1164.
SchwartzPJ. Cardiac sympathetic innervation and the sudden infant death syndrome a possible pathogenic link. Am J Med. 1976;60:167–172.
76.
SchwartzPJPrioriSGDumaineR. A molecular link between the sudden infant death syndrome and the long-QT interval. N Engl J Med. 2000;343:262–267.
77.
TeslerDJAckermanMJ. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu Rev Med. 2009;60:69–84.
78.
ArnestadMCrottiLRognumTO. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007;115:361–367.
79.
TanBHPundiKNVan NorstrandDW. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm. 2010;7:771–778.
80.
HuntDPJTangK. Long QT syndrome presenting as epileptic seizures in an adult. Emerg Med. 2005;22:600–601.
81.
ParisiPOlivaAColl VidalM. Coexistence of epilepsy and Brugada syndrome in a family with SCN5A. Epilepsy Res. 2013;105:415–418.
82.
AurlienDLerenTPTaubollE. New SCN5A mutation in a SUDEP victim with idiopatic epilepsy. Seizure. 2009;18:158–160.
83.
JohnsonJNHofmanNHaglundCM. Identification of a possible pathogenic link between long QT syndrome and epilepsy. Neurology. 2009;72:224–231.
84.
PaciaSVDevinskyOLucianoDJ. The Prolonged QT syndrome presenting as epilepsy: a report of two cases and literature review. Neurology. 1994;44:1408–1410.
85.
SkinnerJRChungSNelC. Brugada syndrome masquerading as febrile seizures. Pediatrics. 2007;119:1206–1211.
86.
ChockalingamPRammelooLAPostemaPG. Fever-induced life threatening arrhythmias in children harboring an SCN5A mutation. Pediatrics. 2010;127:239–244.
87.
VeeramahKRO’BrienJEMeislerMH. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90:502–510.
88.
SandorfiGClemensBCsanadiZ. Electrical storm in the brain and in the heart: epilepsy and Brugada syndrome. Mayo Clin Proc. 2013;88:1167–1173.
89.
KalumeFWestenbroekRECheahCS. Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest. 2013;123:1798–1808.
90.
TangLLuXTaoY. Seizures: a meta-analysis. Gene. 2014;533:26–31.
91.
NakayamaJArinamiT. Molecular genetics of febrile seizures. Epilepsy Res. 2006;(suppl 1):S190–S198.
92.
AndreasenCRefsgaardLNielsenJB. Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data. Can J Cardiol. 2013;29:1104–1109.
93.
GiudicessiJRAckermanMJ. Genotype-and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol. 2013;38:417–455.
94.
CupelloAFavaleEAudeninoD. Decrease of serotonin transporters in blood platelets after epileptic seizures. Neurochem Res. 2005;30:425–428.
95.
HolmesGLBen-AriY. A single episode of neonatal seizures permanently alters glutaminergic synapses. Ann Neurol. 2007;61:379–381.
96.
ZelnikNKahanaLRafaelA. Prolactin and cortisol levels in various paroxysmal disorders in childhood. Pediatrics. 1991;88:486–490.
97.
DirikESenAAnal O CevikNT. Serum cortisol and prolactin levels in childhood paroxysmal disorders. Acta Paediatr Japn. 1996;38:118–120.
98.
BazilCWShortDCrispinD. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology. 2000;55:1746–1748.
99.
SchechtmanVLHarperRMWilsonAJ. Sleep state organization in normal infants and victims of the sudden infant death syndrome. Pediatrics. 1992;89:865–870.
100.
SchuchmannSHauckSHenningS. Respiratory alkalosis in children with febrile seizures. Epilepsia. 2011;52:1949–1955.
101.
BoboWVDavisRLTohS. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinatal Epidemiol. 2012;26:578–588.
102.
CooperWOWillyMEPontSJRayWA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196:544.e1–544e.5.
103.
HerbstFGortnerL. Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy. Zeitschrift Geburtshilfe Neonatol. 2003;207:232–234.
104.
PoetsCFMenyRGChobabianMR. Gasping and other cardiorespiratory patterns during sudden infant deaths. Pediatr Res. 1999;45:350–354.
105.
KinneyHCRognumTONattieEE. Sudden and unexpected death in early life: proceedings of a symposium in honor of Dr. Henry F. Krous. Forensic Sci Med Pathol. 2012;8:441–446.
